Clinical trial
Drug Response in Patient-derived Organoids Models of Advanced or Recurrent Ovarian Cancer, an Exploratory Research
NCT05290961 is registered in ClinicalTrials.gov with Chongqing University Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Response in Patient-derived Organoids Models of Advanced or Recurrent Ovarian Cancer, an Exploratory Research
- Lead sponsor
- Chongqing University Cancer Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 9, 2022
- Completion date
- December 31, 2024
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.